FIRST-IN-KIND T CELLS CARRYING A CHIMERIC ANTIGEN RECEPTOR AGAINST AN EXTRACELLULAR MATRIX PROTEIN TARGET GLIOBLASTOMA CELLS AND SHOW ANTITUMOR EFFICACY

被引：0
|
作者：
Sengupta, Sadhak [1 ]
Nandhu, Mohan [2 ]
Longo, Sharon [3 ]
Sengupta, Sudarshana [4 ]
Longo, John [2 ]
Sampath, Prakash [4 ]
Viapiano, Mariano [3 ]
机构：
[1] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA
[2] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
[3] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA
[4] Roger Williams Med Ctr, Providence, RI USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IMMU-39
引用
收藏
页码：129 / 130
页数：2
相关论文
共 50 条
  • [41] Synergistic Antitumor Effects of Chimeric Antigen Receptor-Modified T Cells and Oncolytic Virotherapy
    Wang, Xingbing
    Gottschalk, Stephen
    Song, Xiao-Tong
    BLOOD, 2014, 124 (21)
  • [42] Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
    O'Hara, Mark
    Stashwick, Caitlin
    Haas, Andrew R.
    Tanyi, Janos L.
    IMMUNOTHERAPY, 2016, 8 (04) : 449 - 460
  • [43] TARGETING GLIOBLASTOMA WITH DNAM-1-BASED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS
    Weiss, Tobias
    Meister, Hanna
    Weller, Michael
    Sentman, Charles
    Roth, Patrick
    NEURO-ONCOLOGY, 2019, 21 : 122 - 122
  • [44] GLIOBLASTOMA MULTIFORME TUMOR VOLUME AND PERSISTENCE OF CHIMERIC ANTIGEN RECEPTOR T CELLS FOLLOWING TREATMENT
    Veerappan, Devi
    Thomas, Reena
    NEURO-ONCOLOGY, 2024, 26
  • [45] Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy - Moving Target for Industry?
    Salmikangas, Paula
    Kinsella, Niamh
    Chamberlain, Paul
    PHARMACEUTICAL RESEARCH, 2018, 35 (08)
  • [46] Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
    Paula Salmikangas
    Niamh Kinsella
    Paul Chamberlain
    Pharmaceutical Research, 2018, 35
  • [47] IL-18 secreting chimeric antigen receptor T cells targeting glypican-3show superior persistence and antitumor immunity against hepatocellular carcinoma
    Jeong, Joseph H.
    Chang, Young-Kyun
    Kang, You-Yeon
    Lee, Jeong-Yun
    Lee, Sae-Rom
    Lee, Yun-Kyung
    Kim, Young-Ho
    Kwon, Byoung S.
    CANCER RESEARCH, 2023, 83 (08)
  • [48] First-in-human chimeric antigen receptor t cells target muc1 transmembrane cleavage product
    Bamdad, Cynthia
    Stewart, Andrew K.
    Huang, Pengyu
    Smagghe, Benoit J.
    Moe, Scott T.
    Swanson, Tyler E.
    Jeon, Thomas G.
    Page, Danica M.
    Grant, Trevor J.
    Specht, Jennifer M.
    CANCER RESEARCH, 2021, 81 (04)
  • [49] Advances in Promoting the Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Hepatocellular Carcinoma
    Shen, Jie
    Yang, Dashuai
    Ding, Youming
    CANCERS, 2022, 14 (20)
  • [50] Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
    Brown, Christine E.
    Aguilar, Brenda
    Starr, Renate
    Yang, Xin
    Chang, Wen-Chung
    Weng, Lihong
    Chang, Brenda
    Sarkissian, Aniee
    Brito, Alfonso
    Sanchez, James F.
    Ostberg, Julie R.
    D'Apuzzo, Massimo
    Badie, Behnam
    Barish, Michael E.
    Forman, Stephen J.
    MOLECULAR THERAPY, 2018, 26 (01) : 31 - 44
12345